{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604-921-1810", "fax": "604-921-1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams M.D.", "age": 69, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 734419, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 51, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 443000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 357745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H., MPH", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 540329, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 77, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 241138, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.7, "open": 3.64, "dayLow": 3.44, "dayHigh": 3.7799, "regularMarketPreviousClose": 3.7, "regularMarketOpen": 3.64, "regularMarketDayLow": 3.44, "regularMarketDayHigh": 3.7799, "payoutRatio": 0.0, "beta": 1.857, "forwardPE": -8.897436, "volume": 31399, "regularMarketVolume": 31399, "averageVolume": 583810, "averageVolume10days": 47740, "averageDailyVolume10Day": 47740, "bid": 3.47, "ask": 4.44, "bidSize": 1, "askSize": 1, "marketCap": 12887164, "fiftyTwoWeekLow": 0.35, "fiftyTwoWeekHigh": 7.87, "fiftyDayAverage": 3.6622, "twoHundredDayAverage": 1.50295, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7482072, "profitMargins": 0.0, "floatShares": 3199281, "sharesOutstanding": 3709440, "sharesShort": 188090, "sharesShortPriorMonth": 202320, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0507, "heldPercentInsiders": 0.12956001, "heldPercentInstitutions": 0.14045, "shortRatio": 1.48, "shortPercentOfFloat": 0.052699998, "impliedSharesOutstanding": 3713880, "bookValue": 1.223, "priceToBook": 2.8372853, "lastFiscalYearEnd": 1722384000, "nextFiscalYearEnd": 1753920000, "mostRecentQuarter": 1738281600, "netIncomeToCommon": -11592001, "trailingEps": -4.75, "forwardEps": -0.39, "lastSplitFactor": "1:300", "lastSplitDate": 1577923200, "enterpriseToEbitda": -0.275, "52WeekChange": 0.20486116, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 3.47, "targetHighPrice": 32.0, "targetLowPrice": 15.0, "targetMeanPrice": 23.5, "targetMedianPrice": 23.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5013654, "totalCashPerShare": 1.352, "ebitda": -27190304, "totalDebt": 0, "quickRatio": 1.369, "currentRatio": 1.369, "returnOnAssets": -1.58141, "freeCashflow": -11424954, "operatingCashflow": -21994862, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketTime": 1743537600, "marketState": "PRE", "regularMarketChangePercent": -6.216217, "regularMarketPrice": 3.47, "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "exchange": "NCM", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketChange": -0.23000002, "regularMarketDayRange": "3.44 - 3.7799", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 583810, "fiftyTwoWeekLowChange": 3.1200001, "fiftyTwoWeekLowChangePercent": 8.914287, "fiftyTwoWeekRange": "0.35 - 7.87", "fiftyTwoWeekHighChange": -4.3999996, "fiftyTwoWeekHighChangePercent": -0.5590851, "fiftyTwoWeekChangePercent": 20.486116, "dividendDate": 1577923200, "earningsTimestamp": 1741809600, "earningsTimestampStart": 1749758400, "earningsTimestampEnd": 1750104000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.75, "epsForward": -0.39, "fiftyDayAverageChange": -0.19219995, "fiftyDayAverageChangePercent": -0.0524821, "twoHundredDayAverageChange": 1.9670501, "twoHundredDayAverageChangePercent": 1.3087928, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1331731800000, "displayName": "BriaCell Therapeutics", "trailingPegRatio": null}